Results 171 to 180 of about 45,942 (277)

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment [PDF]

, 2006

core   +1 more source

Lateral pharyngeal approach in surgery for malignant tumors of the posterior wall of the hypopharynx. [PDF]

Medicine (Baltimore)
Chen Q, Liu X, Chen Z, Shao Q, Lv H, Lin L.   +5 more
europepmc   +1 more source

Adenosquamous Carcinoma of Hypopharynx with Intestinal-Phenotype

Head and Neck Pathology, 2015
M. Magalhaes, J. Irish, I. Weinreb, B. Perez–Ordoñez   +3 more
semanticscholar   +1 more source

Developments in diagnosis and treatment of early hypopharyngeal carcinoma and precancerous lesions: A review. [PDF]

Medicine (Baltimore)
Cheng J, Liu Y, Tang X, Zhao R, Bao Y.
europepmc   +1 more source

Efficacy and Safety of Different Neoadjuvant Treatment Regimens in Locally Advanced Squamous Head and Neck Cancer. [PDF]

Cancer Rep (Hoboken)
Ding YT, Fang BB, Zhu LB, Qiu KJ, Yang LL, Ye H, Lv YX, Cai GM.   +7 more
europepmc   +1 more source

Re-defining standards of care in resectable head and neck squamous cell carcinoma-lessons from KEYNOTE-689 and NIVOPOSTOP. [PDF]

Oncologist
Mehra S, Yom SS, Burtness B.
europepmc   +1 more source

Prevalence of Subclinical Internal Jugular Vein Thrombosis After Microvascular Head and Neck Reconstruction. [PDF]

Microsurgery
Kurita D, Miyamoto S, Saito Y, Kobayashi K, Fujisawa K, Okazaki M.   +5 more
europepmc   +1 more source

Risk Factors for Suicide in Patients With Head and Neck Squamous Cell Carcinoma. [PDF]

Cureus
Nishiguchi T, Tojima I, Yamazaki K, Kawakita K, Kubo Y, Sudo T, Matsumoto K, Owaki S, Takenaka Y.   +8 more
europepmc   +1 more source

Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial. [PDF]

Curr Oncol
Yamashita G, Okada T, Okamoto I, Kondo T, Ito T, Fujii S, Kishida T, Aihara Y, Hanyu K, Ueda Y, Tokashiki K, Sato H, Harada Y, Momiyama K, Matsuki T, Kushihashi Y, Masubuchi T, Tada Y, Yamashita T, Tsukahara K.   +19 more
europepmc   +1 more source

Immunotherapy monotherapy for patients with recurrent nonmetastatic larynx cancer who refuse salvage total laryngectomy. [PDF]

Front Oncol
Shires CB, Sebelik ME.
europepmc   +1 more source